These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 1711544

  • 1. Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors.
    Nagayama Y, Wadsworth HL, Russo D, Chazenbalk GD, Rapoport B.
    J Clin Invest; 1991 Jul; 88(1):336-40. PubMed ID: 1711544
    [Abstract] [Full Text] [Related]

  • 2. Thyroid stimulatory autoantibodies in different patients with autoimmune thyroid disease do not all recognize the same components of the human thyrotropin receptor: selective role of receptor amino acids Ser25-Glu30.
    Nagayama Y, Rapoport B.
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1425-30. PubMed ID: 1361193
    [Abstract] [Full Text] [Related]

  • 3. [Analysis of epitopes for TSH receptor autoantibodies using TSH receptor/LH-CG receptor chimeras].
    Tahara K, Yamamoto K, Tamura Y, Yoshida S.
    Nihon Rinsho; 1994 Apr; 52(4):1031-6. PubMed ID: 7515118
    [Abstract] [Full Text] [Related]

  • 4. Further studies of amino acids (268-304) in thyrotropin (TSH)--lutropin/chorionic gonadotropin (LH/CG) receptor chimeras: cysteine-301 is important in TSH binding and receptor tertiary structure.
    Akamizu T, Inoue D, Kosugi S, Kohn LD, Mori T.
    Thyroid; 1994 Apr; 4(1):43-8. PubMed ID: 8054860
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S, Ban T, Akamizu T, Kohn LD.
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function.
    Nagayama Y, Wadsworth HL, Chazenbalk GD, Russo D, Seto P, Rapoport B.
    Proc Natl Acad Sci U S A; 1991 Feb 01; 88(3):902-5. PubMed ID: 1992482
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
    Tahara K, Ishikawa N, Yamamoto K, Hirai A, Ito K, Tamura Y, Yoshida S, Saito Y, Kohn LD.
    Thyroid; 1997 Dec 01; 7(6):867-77. PubMed ID: 9459630
    [Abstract] [Full Text] [Related]

  • 11. High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain.
    Nagayama Y, Takeshita A, Luo W, Ashizawa K, Yokoyama N, Nagataki S.
    Thyroid; 1994 Dec 01; 4(2):155-9. PubMed ID: 7919997
    [Abstract] [Full Text] [Related]

  • 12. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N, Tuppal R, Hawe BS, Briones-Urbina R, Farid NR.
    J Cell Biochem; 1986 Dec 01; 31(2):107-20. PubMed ID: 2426288
    [Abstract] [Full Text] [Related]

  • 13. Chimeric studies of the extracellular domain of the rat thyrotropin (TSH) receptor: amino acids (268-304) in the TSH receptor are involved in ligand high affinity binding, but not in TSH receptor-specific signal transduction.
    Akamizu T, Inoue D, Kosugi S, Ban T, Kohn LD, Imura H, Mori T.
    Endocr J; 1993 Jun 01; 40(3):363-72. PubMed ID: 7920890
    [Abstract] [Full Text] [Related]

  • 14. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.
    Minich WB, Loos U.
    Exp Clin Endocrinol Diabetes; 2000 Jun 01; 108(2):110-9. PubMed ID: 10826518
    [Abstract] [Full Text] [Related]

  • 15. Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients.
    Tahara K, Ban T, Minegishi T, Kohn LD.
    Biochem Biophys Res Commun; 1991 Aug 30; 179(1):70-7. PubMed ID: 1883391
    [Abstract] [Full Text] [Related]

  • 16. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS, Cunningham SJ, Patibandla SA, Seetharamaiah GS, Morris JC, Tahara K, Kohn LD, Prabhakar BS.
    Endocrinology; 1996 Aug 30; 137(8):3329-39. PubMed ID: 8754759
    [Abstract] [Full Text] [Related]

  • 17. Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor.
    Watanabe Y, Tahara K, Hirai A, Tada H, Kohn LD, Amino N.
    Thyroid; 1997 Feb 30; 7(1):13-9. PubMed ID: 9086564
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
    Grasso YZ, Kim MR, Faiman C, Kohn LD, Tahara K, Gupta MK.
    Thyroid; 1999 Jun 30; 9(6):531-7. PubMed ID: 10411114
    [Abstract] [Full Text] [Related]

  • 20. Extracellular domain chimeras of the TSH and LH/CG receptors reveal the mid-region (amino acids 171-260) to play a vital role in high affinity TSH binding.
    Nagayama Y, Russo D, Chazenbalk GD, Wadsworth HL, Rapoport B.
    Biochem Biophys Res Commun; 1990 Dec 31; 173(3):1150-6. PubMed ID: 2176485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.